Ads
related to: Treatment Macular Degeneration and Aflibercept- Understanding GA
Learn to recognize the
signs and symptoms of GA.
- Recognize and Refer
Examine multimodal imaging to help
recognize GA in your own patients.
- Understanding GA
visionalivemax.com has been visited by 10K+ users in the past month
Search results
...Met in the Second Phase 2 Clinical Trial of IBI302 (anti-VEGF/complement) in Treating Neovascular...
FOX 8 Cleveland· 1 week agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that...
EMA Approves Ocular Formulation of Bevacizumab
Medscape· 7 days agoEurope has approved the use of monoclonal antibody bevacizumab for the treatment of neovascular age-related macular degeneration.
Innovent's anti-VEGF drug matches Eylea in phase 2 eye disease trial
FierceBiotech· 1 week agoInnovent’s anti-VEGF drug held its own against Regeneron and Bayer’s blockbuster eye disease therapy...
Clearside Biomedical appoints new Chief Medical Officer By Investing.com
Investing.com· 1 week agoClearside Biomedical appoints new Chief Medical Officer
Walgreens' (WBA) AllianceRx Pharmacy Will Distribute VIVJOA
Zacks via Yahoo Finance· 1 week agoImage Source: Zacks Investment Research It also includes Regeneron's Eylea HD (aflibercept)...